Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06649084
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-10-16
Brief Title:
Primary Progressive Aphasia Multicomponent Language Treatment Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Establishing Evidence-based Multicomponent Treatment for Speech and Language in Primary Progressive Aphasia
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Primary progressive aphasia PPA is a progressive neurological disorder that causes a gradual decline in communication ability as a result of selective neurodegeneration of speech and language networks in the brain PPA is a devastating condition affecting adults as young as in their 50s depriving them of the ability to communicate and function in society As a result of improved diagnostic precision PPA is now identified with greater accuracy and frequency and increasingly patients and their families seek options for behavioral treatments to ameliorate the devastating effects on their communication prolong speech language skills and maximize quality of life Speech-language treatment outcomes from our group and others are encouraging confirming that behavioral intervention may lead to improvements in trained behaviors and for some interventions lasting and generalized benefit Most speech-language interventions for individuals with PPA that have been explored in the literature are restitutive or impairment-based in nature and have not addressed the full range of severity and phenotypic variability in this population The investigators will evaluate the utility of a novel multicomponent intervention that incorporates elements of restitutive eg word finding strategic training script training compensatory eg multimodal communication communication book and care partner-focused treatment to meet the needs of individuals varying in clinical presentation and severity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None